Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+8.0%/yr
vs +21.5%/yr prior
5Y CAGR
+13.9%/yr
Recent deceleration
Acceleration
-13.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $350.06M | +8.8% |
| 2024 | $321.61M | +3.8% |
| 2023 | $309.80M | +11.4% |
| 2022 | $278.14M | +26.4% |
| 2021 | $219.98M | +20.3% |
| 2020 | $182.93M | +13.3% |
| 2019 | $161.52M | +26.5% |
| 2018 | $127.72M | +27.8% |
| 2017 | $99.91M | +53.9% |
| 2016 | $64.94M | - |